May 16, 2013 — Leviticus Cardio performed a successful animal surgical trial using its wireless coplanar energy transfer system (CET) for ventricular assist devices (VAD). The surgery was performed at Assaf Harofeh Hospital and produced a 75 percent full system efficiency rate as compared with 78 percent efficiency in vitro.
The animal trials were done using the Leviticus CET system and Jarvik Heart VAD. The CET system performed the energy transfer to the animal body and controlled the VAD pump operation.
In vitro lab tests were conducted using several commercial VAD systems of Thoratec, Heartware, Jarvik Heart and Cleveland Heart. In all these tests, the Leviticus CET system was used to transfer the energy and to control the VAD pumping operation using the Leviticus advanced controller.
VADs are used to extend the lives of thousands of patients suffering from chronic heart failure or waiting for a heart transplant. Leviticus Cardio's wireless CET system powers the VAD without wires, thereby avoiding possible complications like dangerous infections, repeated hospitalizations and severely limiting mobility. In addition, the Leviticus Cardio's system can easily be removed for limited periods of time to give patients complete freedom of movement without any external device attached.
For more information: www.leviticus-cardio.com
April 16, 2024 
